中国妇幼健康研究
中國婦幼健康研究
중국부유건강연구
CHINESE JOURNAL OF MATERNAL AND CHILD HEALTH RESEARCH
2014年
3期
471-473,474
,共4页
刘翠云%王美玲%张春梅%成慧%陈伟娟%田秀成
劉翠雲%王美玲%張春梅%成慧%陳偉娟%田秀成
류취운%왕미령%장춘매%성혜%진위연%전수성
血管内皮生长因子C%肿瘤转移抑制基因%免疫组化%宫颈病变
血管內皮生長因子C%腫瘤轉移抑製基因%免疫組化%宮頸病變
혈관내피생장인자C%종류전이억제기인%면역조화%궁경병변
VEGF-C%nm23 H1%immunohistochemistry%cervical lesions
目的:探讨血管内皮生长因子C( VEGF-C)和肿瘤转移抑制基因( nm23 H1)在宫颈增生性病变发生、发展过程中的表达及其临床意义。方法采用免疫组织化学法检测51例宫颈鳞状细胞癌组织中VEGF-C和nm23 H1的表达水平,以31例宫颈炎性、修复性增生组织,27例宫颈上皮内瘤变组织做对照,对结果进行分析。结果在宫颈炎性、修复性增生组织,宫颈上皮内瘤变及宫颈鳞状细胞癌组织中,VEGF-C的表达分别为3.2%、40.7%、72.5%,3组间比较有显著性差异(χ2=37.702,P<0.01);nm23 H1的表达分别为100.0%、59.2%、33.3%,3组间比较有显著性差异(χ2=35.349,P<0.01)。在宫颈鳞癌组织中, VEGF-C和nm23 H1在伴有淋巴结转移的组织中阳性表达率为87.5%和16.7%;未伴淋巴结转移中阳性表达率为59.3%和48.1%。在宫颈增生性病变组织中,无论有无淋巴结转移,VEGF-C与nm23 H1阳性表达始终呈负相关(r=-0.532,P<0.05)。结论 VEGF-C和nm23 H1存在相关性,并在宫颈鳞癌的发生、发展、预后和转移方面发挥着重要作用,其可作为评价宫颈病变、推测预后的重要参考指标。
目的:探討血管內皮生長因子C( VEGF-C)和腫瘤轉移抑製基因( nm23 H1)在宮頸增生性病變髮生、髮展過程中的錶達及其臨床意義。方法採用免疫組織化學法檢測51例宮頸鱗狀細胞癌組織中VEGF-C和nm23 H1的錶達水平,以31例宮頸炎性、脩複性增生組織,27例宮頸上皮內瘤變組織做對照,對結果進行分析。結果在宮頸炎性、脩複性增生組織,宮頸上皮內瘤變及宮頸鱗狀細胞癌組織中,VEGF-C的錶達分彆為3.2%、40.7%、72.5%,3組間比較有顯著性差異(χ2=37.702,P<0.01);nm23 H1的錶達分彆為100.0%、59.2%、33.3%,3組間比較有顯著性差異(χ2=35.349,P<0.01)。在宮頸鱗癌組織中, VEGF-C和nm23 H1在伴有淋巴結轉移的組織中暘性錶達率為87.5%和16.7%;未伴淋巴結轉移中暘性錶達率為59.3%和48.1%。在宮頸增生性病變組織中,無論有無淋巴結轉移,VEGF-C與nm23 H1暘性錶達始終呈負相關(r=-0.532,P<0.05)。結論 VEGF-C和nm23 H1存在相關性,併在宮頸鱗癌的髮生、髮展、預後和轉移方麵髮揮著重要作用,其可作為評價宮頸病變、推測預後的重要參攷指標。
목적:탐토혈관내피생장인자C( VEGF-C)화종류전이억제기인( nm23 H1)재궁경증생성병변발생、발전과정중적표체급기림상의의。방법채용면역조직화학법검측51례궁경린상세포암조직중VEGF-C화nm23 H1적표체수평,이31례궁경염성、수복성증생조직,27례궁경상피내류변조직주대조,대결과진행분석。결과재궁경염성、수복성증생조직,궁경상피내류변급궁경린상세포암조직중,VEGF-C적표체분별위3.2%、40.7%、72.5%,3조간비교유현저성차이(χ2=37.702,P<0.01);nm23 H1적표체분별위100.0%、59.2%、33.3%,3조간비교유현저성차이(χ2=35.349,P<0.01)。재궁경린암조직중, VEGF-C화nm23 H1재반유림파결전이적조직중양성표체솔위87.5%화16.7%;미반림파결전이중양성표체솔위59.3%화48.1%。재궁경증생성병변조직중,무론유무림파결전이,VEGF-C여nm23 H1양성표체시종정부상관(r=-0.532,P<0.05)。결론 VEGF-C화nm23 H1존재상관성,병재궁경린암적발생、발전、예후화전이방면발휘착중요작용,기가작위평개궁경병변、추측예후적중요삼고지표。
Objective To explore the expression and clinical significance of VEGF-C and nm23 H1 in the occurrence and development of cervical hyperplasia lesions .Methods Immunohistochemistry was used to test the expression of VEGF-C and nm23 H1 in 51 samples of cervical squamous cell carcinoma tissues .The control group included 31 samples of normal cervical , inflammatory or reparative hyperplasia tissues and 27 samples of cervical intraepithelial neoplasia tissues .The results were analyzed .Results In cervical inflammatory and reparative hyperplasia tissues , cervical intraepithelial neoplasia tissues and cervical squamous cell carcinoma tissues , the positive expression rate of VEGF-C was 3.2%, 40.7%and 72.5%, respectively.The difference among them was significant (χ2 =37.702, P<0.01).The expression of nm23 H1 was 100.0%, 59.2%and 33.3%, respectively, and there was significant difference (χ2 =35.349, P<0.01).The positive expression rate of VEGF-C and nm23 H1 were 87.5%and 16.7%, respectively in cervical carcinoma tissue with lymph node metastasis, and 59.3% and 48.1%, respectively in cervical carcinoma tissue without lymph node metastasis .VEGF-C expression was negatively correlated with nm 23 H1 in cervical hyperplasia lesions with or without lymph nodes metastasis (r=-0.532,P<0.05).Conclusion VEGF-C is correlated with nm23 H1, and they play an important role in the occurrence , development, prognosis and metastasis of cervical squamous cell carcinoma , which may be important reference indexes for evaluating severity and predicting prognosis of cervical lesions .